{
    "nctId": "NCT02315287",
    "officialTitle": "Comparison of Therapeutic Efficacy Between Lobeglitazone and Pioglitazone as Initial Triple Therapy With Metformin and Sitagliptin in Drug-na\u00efve Type 2 Diabetic Patients",
    "inclusionCriteria": "* HbA1c \\> 13.0 %\n* No treatment with insulin or oral agents for 6 months\n* 20 \u2264 Age \\< 80 years\n* Must have minimum age of 20 Years\n* Must have maximum age of 80 Years",
    "exclusionCriteria": "* Contraindication to sitagliptin or metformin or thiazolidinedione\n* Pregnant or breast feeding women\n* Type 1 diabetes, gestational diabetes, or secondary forms of diabetes\n* Not appropriate for oral antidiabetic agent\n* Medication which affect glycemic control\n* Disease which affect efficacy and safety of drugs\n* Any major illness (Liver disease, Renal failure, Heart disease, Cancer, etc)"
}